Why PRP also needs organisational planning

A PRP session is not just the price of a tube. In practice, several cost blocks arise: consumables, device depreciation, staff time, room time, documentation, patient information, billing, hygiene measures and disposal. If these items are not separated clearly, the calculation can become too optimistic.

This is where a simple cost-benefit analysis helps. It does not replace individual fee or tax advice, but it makes visible which factors influence the contribution margin. This is useful when PRP is added to the practice portfolio or when an existing PRP offer needs to be reviewed.

Planning material use: the surface-area rule as a practical guide

A common question is: how many PRP tubes are needed per treatment? One practical approach is to look at the size of the treatment area. As a rough planning value, an area roughly the size of a palm can be calculated with about one PRP tube. This is not a medical standard and not a guarantee of a specific PRP yield, but a pragmatic tool for material and appointment planning.

Which costs belong in a PRP calculation

A robust calculation separates direct costs, time costs and fixed costs. With PRP, small items are often underestimated. Individually they may look minor, but over a month or a treatment series they can be relevant.

Calculating contribution margin: a simple formula

For a first assessment, a clear contribution-margin calculation is often enough. It shows what remains per session after directly attributable costs have been deducted. This can later indicate how quickly a centrifuge or a new PRP setup may amortise.

The word “net” matters. Depending on medical or aesthetic indication, tax treatment may differ. This should be checked with tax advice or a billing partner before prices or treatment packages are published.

Example calculation for orientation

The following calculation is intentionally a model. It does not replace an individual calculation and does not use binding market prices.

Example: if the initial investment for centrifuge and starter equipment is €1,500 and the calculated contribution margin is €195 per session, the mathematical break-even would be reached after about 8 sessions. This is not a profit promise, only a simple business model.

Setting prices: combine market, billing rules and internal costs

Economic pricing should not be based only on competitors. A better approach combines internal cost calculation, physician time, intended positioning, local market environment and correct billing.

• Describe the service clearly: information, blood draw, preparation, application and follow-up.
• Separate material costs, medical service and organisational effort.
• For medical services in Germany, GOÄ or a suitable analogue valuation should be checked.
• Material expenses should not be charged arbitrarily; GOÄ rules for expenses may be relevant.
• For aesthetic services without medical indication, VAT treatment should be clarified in advance.
• Packages should not be worded as a medical success guarantee.

System choice: efficiency comes from standardisation

A PRP system should not be selected only by tube price. Process reliability, handling, required centrifugation time, final PRP volume, documentation, storage and intended purpose of the medical devices used are also relevant in practice.

Systems with separation gel can support the separation of blood components within a defined protocol. The tube, centrifuge and practice protocol must fit together. Economically, a slightly higher material price may still make sense if the process is reproducible, easy to document and reliable in daily practice.

Product references to PRP tubes should remain strictly material- and process-related. The choice of a tube must not be used to imply treatment success.

Typical PRP calculation errors

Economic problems in practice rarely come from one big mistake. Usually, several small points have not been accounted for properly.

• Calculating only the tube price and forgetting accessories, disposal and documentation.
• Not calculating physician time, although consultation and application are major value components.
• Discounting treatment series too strongly without checking contribution margin.
• Charging materials as a flat fee without checking billability.
• Treating aesthetic and medically indicated services the same for tax purposes.
• Confusing product quality with treatment success and using overly strong advertising claims.

Conclusion: plan PRP economically without overstating medicine

PRP can be economically interesting for practices when process, material use, time and pricing are calculated cleanly. The key is not a big promise, but clear planning: how many tubes are realistically needed? How long does the appointment really take? Which disposables are used? Which investment has to amortise over how many cases?

A good PRP calculation is transparent, traceable and legally cautious. It separates economic planning from medical efficacy claims. That creates an offer that is professionally clear, organisationally manageable and economically understandable.

Sources and further notes

1. Bundesärztekammer: GOÄ-Ratgeber: Behandlung mit plättchenreichem Plasma und Hyaluronsäure
2. Bundesärztekammer: Analoge Bewertungen in der GOÄ – Einführung
3. Bundesärztekammer: § 10 GOÄ: Auslagen
4. Bundesministerium der Finanzen: Umsatzsteuerbefreiung nach § 4 Nr. 14 UStG für ästhetische Behandlungen
5. Heilmittelwerbegesetz: § 3 HWG – Irreführende Werbung